HMC Capital Ltd (ASX: HMC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
HMC Capital Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
HMC Capital Ltd (ASX: HMC)
Latest News
Financial Shares
This ASX financials stock just soared 11% on results and is tipped to keep rising
Earnings Results
HMC Capital share price on watch as FY26 earnings meet guidance, FY27 growth targeted
Broker Notes
Three ASX shares with fresh buy recommendations to target this week
Share Gainers
Why DigiCo, HMC Capital, Infratil, and Qantas shares are taking off today
Value Investing
After crashing 57%, this ASX value stock looks filthy cheap with a P/E of just 7
52-Week Lows
4 ASX All Ords shares at 52-week lows. Should you buy?
Broker Notes
Buy, hold, sell: HMC Capital, Ramsay Health Care, and Sigma shares
Dividend Investing
35 ASX All Ords shares with ex-dividend dates next week
Financial Shares
How does Bell Potter view these ASX financials stocks after earnings season?
Dividend Investing
Guess which ASX stock could pay a 9% dividend yield in 2027
Share Fallers
Why Bougainville Copper, Brainchip, Challenger, and HMC Capital shares are falling today
Dividend Investing
1 ASX dividend stock down 64% I'd buy right now
Frequently Asked Questions
-
Yes, HMC Capital has historically paid largely fully franked shareholder dividends twice a year.
-
HMC Capital generally pays its shareholder dividends in April and October.
-
HMC Capital Ltd listed on the ASX on 14 October 2019.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 01 Sep 2026 | $0.0600 | 0.00% | Final | 07 Oct 2026 |
| 03 Mar 2026 | $0.0600 | 16.67% | Interim | 09 Apr 2026 |
| 26 Aug 2025 | $0.0600 | 0.00% | Final | 30 Sep 2025 |
| 25 Feb 2025 | $0.0600 | 100.00% | Interim | 01 Apr 2025 |
| 27 Aug 2024 | $0.0600 | 70.00% | Final | 02 Oct 2024 |
| 26 Feb 2024 | $0.0600 | 0.00% | Interim | 02 Apr 2024 |
| 29 Aug 2023 | $0.0600 | 10.00% | Final | 04 Oct 2023 |
| 01 Mar 2023 | $0.0600 | 100.00% | Interim | 06 Apr 2023 |
| 01 Sep 2022 | $0.0600 | 100.00% | Final | 07 Oct 2022 |
| 01 Mar 2022 | $0.0600 | 100.00% | Interim | 07 Apr 2022 |
| 02 Sep 2021 | $0.0600 | 50.00% | Final | 01 Oct 2021 |
| 02 Mar 2021 | $0.0600 | 100.00% | Interim | 17 Mar 2021 |
| 03 Sep 2020 | $0.0750 | 100.00% | Final | 18 Sep 2020 |
| 04 Mar 2020 | $0.0450 | 100.00% | Interim | 19 Mar 2020 |
HMC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About HMC Capital Ltd
HMC Capital Ltd (ASX: HMC) is a diversified alternative asset manager with more than $19.5 billion of assets under management (AUM) as of February 2026, spanning real estate, private equity, energy transition, private credit, and digital infrastructure.
Several listed real estate investment trusts (REITs), including HomeCo Daily Needs REIT, HealthCo Healthcare and Wellness REIT, and DigiCo Infrastructure REIT, operate under the company structure alongside several unlisted funds.
HMC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Sep 2026 | $3.25 | $-0.20 | -5.80% | 1,157,958 | $3.32 | $3.39 | $3.24 |
| 10 Sep 2026 | $3.45 | $-0.01 | -0.29% | 1,229,011 | $3.44 | $3.48 | $3.40 |
| 09 Sep 2026 | $3.46 | $0.14 | 4.22% | 1,254,837 | $3.34 | $3.47 | $3.31 |
| 08 Sep 2026 | $3.32 | $-0.06 | -1.78% | 1,321,714 | $3.36 | $3.38 | $3.24 |
| 07 Sep 2026 | $3.38 | $0.02 | 0.60% | 999,715 | $3.30 | $3.42 | $3.30 |
| 04 Sep 2026 | $3.36 | $0.26 | 8.39% | 1,938,505 | $3.16 | $3.38 | $3.16 |
| 03 Sep 2026 | $3.10 | $-0.04 | -1.27% | 1,520,485 | $3.14 | $3.24 | $3.10 |
| 02 Sep 2026 | $3.14 | $-0.06 | -1.88% | 1,809,882 | $3.15 | $3.23 | $3.09 |
| 01 Sep 2026 | $3.20 | $-0.05 | -1.54% | 1,543,211 | $3.60 | $3.60 | $3.11 |
| 31 Aug 2026 | $3.25 | $-0.09 | -2.69% | 1,634,515 | $3.28 | $3.36 | $3.23 |
| 28 Aug 2026 | $3.34 | $-0.04 | -1.18% | 1,917,195 | $3.54 | $3.54 | $3.30 |
| 27 Aug 2026 | $3.38 | $0.12 | 3.68% | 7,847,968 | $3.40 | $3.59 | $3.32 |
| 26 Aug 2026 | $3.26 | $0.33 | 11.26% | 6,878,782 | $3.02 | $3.46 | $2.92 |
| 25 Aug 2026 | $2.93 | $0.01 | 0.34% | 357,550 | $2.92 | $2.95 | $2.89 |
| 24 Aug 2026 | $2.92 | $-0.02 | -0.68% | 558,362 | $2.98 | $2.99 | $2.90 |
| 21 Aug 2026 | $2.94 | $-0.06 | -2.00% | 527,384 | $3.05 | $3.05 | $2.91 |
| 20 Aug 2026 | $3.00 | $0.01 | 0.33% | 1,515,789 | $2.97 | $3.03 | $2.96 |
| 19 Aug 2026 | $2.99 | $-0.01 | -0.33% | 973,671 | $3.00 | $3.01 | $2.94 |
| 18 Aug 2026 | $3.00 | $-0.02 | -0.66% | 472,586 | $3.01 | $3.05 | $2.99 |
| 17 Aug 2026 | $3.02 | $-0.01 | -0.33% | 584,470 | $3.04 | $3.05 | $2.98 |
| 14 Aug 2026 | $3.03 | $-0.03 | -0.98% | 240,969 | $3.07 | $3.08 | $3.02 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 27 Aug 2026 | Christopher Roberts | Buy | 8,560 | $28,932 |
Conversion of securities.
|
| 27 Aug 2026 | Christopher Roberts | Exercise | 8,560 | $28,932 |
Conversion of securities.
|
| 27 Aug 2026 | Gregory (Greg) Hayes | Exercise | 13,547 | $45,788 |
Conversion of securities.
|
| 27 Aug 2026 | Gregory (Greg) Hayes | Buy | 13,547 | $45,788 |
Conversion of securities.
|
| 27 Aug 2026 | Fiona Pak-Poy | Exercise | 7,846 | $26,519 |
Conversion of securities.
|
| 27 Aug 2026 | Fiona Pak-Poy | Buy | 7,846 | $26,519 |
Conversion of securities.
|
| 27 Aug 2026 | Christopher Saxon | Buy | 17,833 | $60,275 |
Conversion of securities.
|
| 27 Aug 2026 | Christopher Saxon | Exercise | 17,833 | $60,275 |
Conversion of securities.
|
| 27 Aug 2026 | Kelly O'Dwyer | Exercise | 10,700 | $36,166 |
Conversion of securities.
|
| 27 Aug 2026 | Kelly O'Dwyer | Buy | 10,700 | $36,166 |
Conversion of securities.
|
| 27 Aug 2026 | Susan Roberts | Exercise | 9,986 | $33,752 |
Conversion of securities.
|
| 27 Aug 2026 | Susan Roberts | Buy | 9,986 | $33,752 |
Conversion of securities.
|
| 25 Feb 2026 | Susan Roberts | Exercise | 9,986 | $28,060 |
Conversion of securities. 9,986 rights
|
| 25 Feb 2026 | Susan Roberts | Buy | 9,986 | $28,060 |
Conversion of securities.
|
| 25 Feb 2026 | Kelly O'Dwyer | Exercise | 10,700 | $30,067 |
Conversion of securities. 10,700 rights
|
| 25 Feb 2026 | Kelly O'Dwyer | Buy | 10,700 | $30,067 |
Conversion of securities.
|
| 25 Feb 2026 | Fiona Pak-Poy | Exercise | 7,846 | $22,047 |
Conversion of securities. 7,846 rights
|
| 25 Feb 2026 | Fiona Pak-Poy | Buy | 7,846 | $22,047 |
Conversion of securities.
|
| 25 Feb 2026 | Christopher Saxon | Exercise | 17,833 | $50,110 |
Conversion of securities. 17,833 rights
|
| 25 Feb 2026 | Christopher Saxon | Buy | 17,833 | $50,110 |
Conversion of securities.
|
| 25 Feb 2026 | Gregory (Greg) Hayes | Exercise | 7,846 | $22,047 |
Conversion of securities. 13,547 rights
|
| 25 Feb 2026 | Gregory (Greg) Hayes | Buy | 7,846 | $22,047 |
Conversion of securities.
|
| 25 Feb 2026 | Christopher Roberts | Exercise | 8,560 | $24,053 |
Conversion of securities. 8,560 rights
|
| 25 Feb 2026 | Christopher Roberts | Buy | 8,560 | $24,053 |
Conversion of securities.
|
| 27 Nov 2025 | Gregory (Greg) Hayes | Issued | 15,692 | $55,706 |
Director remuneration. 21,393 rights
|
| 27 Nov 2025 | Fiona Pak-Poy | Issued | 15,692 | $55,706 |
Director remuneration. 15,692 rights
|
| 27 Nov 2025 | David Di Pilla | Issued | 595,924 | $2,115,530 |
Issue of securities. 1,639,348 performance rights
|
| 27 Nov 2025 | Christopher Saxon | Issued | 35,666 | $126,614 |
Director remuneration. 35,666 rights
|
| 27 Nov 2025 | Susan Roberts | Issued | 19,972 | $70,900 |
Director remuneration. 19,972 rights
|
| 27 Nov 2025 | Christopher Roberts | Issued | 17,120 | $60,776 |
Director remuneration. 17,120 rights
|
| 27 Nov 2025 | Kelly O'Dwyer | Issued | 21,400 | $75,970 |
Director remuneration. 21,400 rights
|
| 21 Nov 2025 | Kelly O'Dwyer | Buy | 32,959 | $104,761 |
On-market trade. 1000 Prior Holding
|
| 30 Sep 2025 | David Di Pilla | Expiry | 179,616 | $571,178 |
As advised by the company. Lapsed, 10,43,424 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Christopher Graham Roberts | Non-Executive Director | Nov 2024 |
Dr Roberts has over 40 years of experience in the medical device industry, serving a few senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, Non-Executive Director of HCW Funds Management Limited (the responsible entity of the HealthCo Healthcare & Wellness REIT, a Non-Executive Director of Sigma Healthcare Limited, Clarity Pharmaceuticals Limited, Atmo Biosciences Ltd, Centenary Institute of Medical Research and Nutromics Pty Ltd. He was also the Executive Vice President of ResMed from 1992 to 2003, and a director until 2017. Chris was a former Chair of Research Australia from 2004 to 2010.
|
| Mr Gregory (Greg) John Hayes | Non-Executive Director | Sep 2019 |
Mr Hayes is currently a Non-Executive Director of Aurrum Holdings Pty Ltd and Future Secure AI Inc. Having worked across industries including property, infrastructure, energy and logistics, his skills and experience include strategy, finance, mergers and acquisitions and strategic risk management, in listed companies with global operations. He was previously a Non-Executive Director of Ingenia Communities, Non-Executive Director of HomeCo Daily Needs REIT, Chief Financial Officer and Executive Director of Brambles Limited, Chief Executive Officer and Group Managing Director of Tenix Pty Ltd, Chief Financial Officer and later interim Chief Executive Officer of the Australian Gaslight Company, Chief Financial Officer Australia and New Zealand of Westfield Holdings, Executive General Manager, Finance of Southcorp Limited. He was a director of Ingenia Communities (until 1 July 2024) and HomeCo Daily Needs REIT (until 13 February 2025).
|
| Ms Fiona Jane Pak-Poy | Non-Executive Director | Nov 2024 |
Ms Pak-Poy is the Chair and Non-Executive director of Tyro Payments Limited. She is on the Board of Trustees and Investment Committee for HMC Capital Partners Fund 1 and is a member of the Business Advisory Council for Anacacia Capital. Fiona has over 30 years of experience in a variety of industries, for companies ranging from startups to listed companies, government entities and not-for-profits. She has served on various boards, including WiseTech Global MYOB, Isentia, Novotech, PageUp People, StatePlus and SIRCA (the Securities Research Centre of South-East Asia). She served on the ASIC director Advisory Panel and the Board of Innovation Australia. Previously She was a strategy consultant for the Boston Consulting Group in the US and Australia and was a General Partner in an Australian venture capital fund focused on technology startups. Fiona is a mentor for the Minerva Network, a member of Chief Executive Women and a Fellow of the Australian Institute of Company Directors. She is the Member of the Sustainability Committee.
|
| Mr David Anthony Di Pilla | Chief Executive OfficerManaging Director | Oct 2017 |
Mr Pilla has over 30 years of experience in investment banking, strategic advisory & consulting and corporate leadership as a Director and CEO. During his 20-year investment banking career David was Managing Director of UBS Investment Bank for over 15 years and during this time led some of Australia landmark transactions across corporate M&A, Equity & Debt Capital Markets. Prior to his time at UBS, David reached the position of Vice President, Investment Banking at JP Morgan. He is a director of HomeCo Daily Needs REIT (appointed on 18 September 2020), HealthCo Healthcare and Wellness REIT (appointed on 28 July 2021), and HMC Digital Infrastructure Limited, which forms part of DigiCo Infrastructure REIT (appointed on 1 November 2024).
|
| Mr Christopher Saxon | Non-Executive DirectorNon-Executive Chairman | Sep 2019 |
Mr Saxon is an Australian lawyer and was, until 2019, a partner with global law firm Baker McKenzie. His practice included mergers and acquisition (M&A) transactions across a range of sectors, notably energy (gas, electricity, renewable), industrials, infrastructure and mining. He has served as lead adviser on government restructuring transactions, privatisations, trade sales, mergers and acquisitions, and infrastructure projects. Chris served as Chair of Baker McKenzie Australia for five years (2012-2017) and held leadership roles within the firm.
|
| Hon Kelly Megan O'Dwyer | Non-Executive Director | Nov 2020 |
Hon O'Dwyer is a Non-Executive Director of EQT Holdings Limited, HealthCo Healthcare and Wellness REIT, DigiCo Infrastructure REIT, Barrenjoey Capital Partners Group Holdings Pty Ltd and the National Reconstruction Fund Corporation. Kelly previously served in the Australian Parliament as a Senior Cabinet Minister holding a few key economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She also served on the Cabinet Budget Committee (the Expenditure Review Committee) and held the portfolios of Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. Prior to entering Parliament, Kelly worked in law, government and finance and brought insights across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is a director of EQT Holdings Limited (appointed on 29 March 2021), HealthCo Healthcare and Wellness REIT (appointed on 1 August 2021), HMC Digital Infrastructure Limited, which forms part of DigiCo Infrastructure REIT (appointed on 1 November 2024), and Magellan Financial Group Ltd (appointed on 1 July 2026). She is the Chair of Sustainability Committee.
|
| Ms Susan Roberts | Non-Executive Director | Nov 2022 |
Ms Roberts is an experienced director and CEO with over 30 years in the financial services, investment and insurance industries. Her current roles include Chair of Audit for AIG Australia and Teachers Health, and she is a director of Metlife Australia. Susan has a technical actuarial and investment background coupled with risk management, business strategy, governance and stakeholder management skills. She has commercial and financial executive experience, including CEO and Managing Director of Lazard Asset Management Pacific, and Director, Strategy at Lend Lease Investment Services. She has previously served as a Non-Executive Director of Maple Brown Abbott and as Chair of the Audit and Risk, and Claims Committee for Zurich Australia Superannuation. Susan was also Chair of the Investor Working Group for the 30% Club in Australia. She is the member of the Sustainability Committee.
|
| Mr Andrew Selim | Company SecretaryGeneral Counsel |
-
|
|
| Andrew Selim | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 133,366,340 | 32.32% |
| Home Investment Consortium Trust | 79,535,204 | 19.28% |
| HSBC Custody Nominees (Australia) Limited 1 | 52,353,491 | 12.69% |
| J P Morgan Nominees Australia Pty Limited | 34,797,438 | 8.43% |
| Netwealth Investments Limited | 12,628,547 | 3.06% |
| BNP Paribas NOMS PTY LTD | 5,079,842 | 1.23% |
| UBS Nominees Pty Ltd | 2,920,370 | 0.71% |
| HSBC Custody Nominees (Australia) Limited | 2,494,385 | 0.60% |
| CW Property Nominees Pty Ltd | 2,238,806 | 0.54% |
| BNP Paribas Nominees Pty Ltd 1 | 2,154,854 | 0.52% |
| BNP Paribas Nominees Pty Ltd | 2,145,007 | 0.52% |
| Aldaoud Pty Ltd | 2,000,000 | 0.48% |
| BNP Paribas Noms (Nz) Ltd | 1,941,529 | 0.47% |
| Pacific Custodians Pty Limited | 1,828,462 | 0.44% |
| Mat Family Foundation Pty Ltd | 1,700,000 | 0.41% |
| BNP Paribas Nominees Pty Ltd 2 | 1,666,203 | 0.40% |
| SG Foundation Investments Pty Ltd | 1,071,014 | 0.26% |
| David Payton Pty Ltd | 968,522 | 0.23% |
| Mr Amer Akkari | 864,344 | 0.21% |
| Ruth Payton Foundation Limited | 835,299 | 0.20% |